Loading...
•
Mar 31, 2020
Teladoc Q1 2020 Earnings Report
Teladoc Health's first quarter results were reported, showing revenue growth and increased total visits.
Key Takeaways
Teladoc Health reported a 41% year-over-year revenue increase to $180.8 million for Q1 2020. Total visits increased by 92% to 2.0 million. The company issued Q2 2020 guidance and updated full-year expectations.
Revenue grew 41% year-over-year to $180.8 million.
Total visits increased 92% year-over-year reaching 2.0 million.
Net loss was $(29.6) million compared to $(30.2) million in the first quarter 2019.
Adjusted EBITDA was $10.7 million compared to $1.2 million for the first quarter 2019.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Teladoc Health provides guidance based on current market conditions and expectations. For the second-quarter 2020, total revenue is expected to be in the range of $215 million to $225 million.
Positive Outlook
- Total revenue to be in the range of $215 million to $225 million.
- EBITDA to be in the range of $(1) million to $3 million.
- Adjusted EBITDA to be in the range of $20 million to $24 million.
- Total U.S. paid membership to be approximately 49 million to 50 million members and visit-fee-only access to be available to approximately 21 to 22 million individuals, including the addition of 2 to 3 million members on a temporary basis.
- Total visits to be between 2.3 million and 2.4 million.
Challenges Ahead
- Net loss per share, based on 74.6 million weighted average shares outstanding, to be between $(0.28) and $(0.23).
- Total revenue to be in the range of $800 million to $825 million for full year 2020.
- EBITDA loss to be in the range of $(14) million to $(4) million for full year 2020.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...